Sumitomo Mitsui Trust Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Buy |
492,104
+24,859
| +5% | +$1.37M | 0.02% | 599 |
|
|
2025
Q1 | $33M | Sell |
467,245
-2,798
| -0.6% | -$198K | 0.02% | 553 |
|
|
2024
Q4 | $30.9M | Buy |
470,043
+13,946
| +3% | +$917K | 0.02% | 578 |
|
|
2024
Q3 | $32.1M | Buy |
456,097
+20,631
| +5% | +$1.45M | 0.02% | 570 |
|
|
2024
Q2 | $35.9M | Sell |
435,466
-42,034
| -9% | -$3.46M | 0.03% | 512 |
|
|
2024
Q1 | $41.7M | Sell |
477,500
-4,096
| -0.9% | -$358K | 0.03% | 547 |
|
|
2023
Q4 | $46.4M | Sell |
481,596
-5,805
| -1% | -$560K | 0.03% | 495 |
|
|
2023
Q3 | $43.1M | Sell |
487,401
-14,122
| -3% | -$1.25M | 0.04% | 495 |
|
|
2023
Q2 | $43.5M | Sell |
501,523
-82,377
| -14% | -$7.14M | 0.03% | 515 |
|
|
2023
Q1 | $56.8M | Sell |
583,900
-2,320
| -0.4% | -$226K | 0.04% | 455 |
|
|
2022
Q4 | $60.7M | Sell |
586,220
-6,472
| -1% | -$670K | 0.05% | 434 |
|
|
2022
Q3 | $50.2M | Buy |
592,692
+3,407
| +0.6% | +$289K | 0.04% | 482 |
|
|
2022
Q2 | $48.8M | Buy |
589,285
+25,294
| +4% | +$2.1M | 0.04% | 520 |
|
|
2022
Q1 | $43.5M | Buy |
563,991
+308
| +0.1% | +$23.7K | 0.03% | 577 |
|
|
2021
Q4 | $49.8M | Buy |
563,683
+34,324
| +6% | +$3.03M | 0.03% | 535 |
|
|
2021
Q3 | $40.9M | Sell |
529,359
-21,497
| -4% | -$1.66M | 0.03% | 590 |
|
|
2021
Q2 | $46M | Sell |
550,856
-35,489
| -6% | -$2.96M | 0.03% | 574 |
|
|
2021
Q1 | $44.3M | Sell |
586,345
-30,584
| -5% | -$2.31M | 0.03% | 577 |
|
|
2020
Q4 | $54.1M | Sell |
616,929
-343,698
| -36% | -$30.1M | 0.04% | 506 |
|
|
2020
Q3 | $73.1M | Buy |
960,627
+242,035
| +34% | +$18.4M | 0.05% | 384 |
|
|
2020
Q2 | $88.6M | Buy |
718,592
+4,257
| +0.6% | +$525K | 0.06% | 332 |
|
|
2020
Q1 | $60.4M | Buy |
714,335
+31,414
| +5% | +$2.65M | 0.05% | 386 |
|
|
2019
Q4 | $57.7M | Buy |
682,921
+10,398
| +2% | +$879K | 0.05% | 422 |
|
|
2019
Q3 | $45.3M | Sell |
672,523
-2,532
| -0.4% | -$171K | 0.04% | 473 |
|
|
2019
Q2 | $57.8M | Sell |
675,055
-69,897
| -9% | -$5.99M | 0.05% | 383 |
|
|
2019
Q1 | $66.2M | Buy |
744,952
+67,321
| +10% | +$5.98M | 0.06% | 335 |
|
|
2018
Q4 | $56.7M | Buy |
677,631
+109,630
| +19% | +$9.17M | 0.06% | 327 |
|
|
2018
Q3 | $55.1M | Buy |
568,001
+12,603
| +2% | +$1.22M | 0.06% | 345 |
|
|
2018
Q2 | $52.3M | Buy |
555,398
+61,915
| +13% | +$5.83M | 0.06% | 347 |
|
|
2018
Q1 | $40M | Buy |
493,483
+3,719
| +0.8% | +$302K | 0.05% | 401 |
|
|
2017
Q4 | $43.7M | Buy |
489,764
+13,598
| +3% | +$1.21M | 0.06% | 360 |
|
|
2017
Q3 | $44.3M | Sell |
476,166
-69,208
| -13% | -$6.44M | 0.06% | 329 |
|
|
2017
Q2 | $49.5M | Buy |
545,374
+45,664
| +9% | +$4.15M | 0.07% | 302 |
|
|
2017
Q1 | $43.9M | Buy |
499,710
+27,335
| +6% | +$2.4M | 0.07% | 316 |
|
|
2016
Q4 | $39.1M | Buy |
472,375
+27,178
| +6% | +$2.25M | 0.06% | 336 |
|
|
2016
Q3 | $41.2M | Buy |
445,197
+2,448
| +0.6% | +$226K | 0.07% | 329 |
|
|
2016
Q2 | $34.4M | Sell |
442,749
-1,979
| -0.4% | -$154K | 0.06% | 360 |
|
|
2016
Q1 | $36.7M | Sell |
444,728
-2,634
| -0.6% | -$217K | 0.06% | 344 |
|
|
2015
Q4 | $47.3M | Sell |
447,362
-2,948
| -0.7% | -$312K | 0.08% | 269 |
|
|
2015
Q3 | $47.4M | Buy |
450,310
+20,795
| +5% | +$2.19M | 0.09% | 261 |
|
|
2015
Q2 | $58.7M | Buy |
429,515
+12,307
| +3% | +$1.68M | 0.11% | 235 |
|
|
2015
Q1 | $52M | Buy |
417,208
+79,122
| +23% | +$9.86M | 0.09% | 261 |
|
|
2014
Q4 | $30.5M | Sell |
338,086
-8,834
| -3% | -$798K | 0.06% | 373 |
|
|
2014
Q3 | $25M | Sell |
346,920
-1,333
| -0.4% | -$96.2K | 0.05% | 424 |
|
|
2014
Q2 | $21.7M | Sell |
348,253
-38,733
| -10% | -$2.41M | 0.04% | 464 |
|
|
2014
Q1 | $26.4M | Buy |
386,986
+28,382
| +8% | +$1.94M | 0.06% | 402 |
|
|
2013
Q4 | $24.9M | Sell |
358,604
-8,976
| -2% | -$622K | 0.05% | 418 |
|
|
2013
Q3 | $26.5M | Buy |
367,580
+45,293
| +14% | +$3.27M | 0.06% | 383 |
|
|
2013
Q2 | $18M | Buy |
+322,287
| New | +$18M | 0.04% | 485 |
|